and L-739,010 to reactive intermediates that covalently bind to protein: the role
of the 6,8-dioxabicyclo[3.2.1]octanyl moiety. Drug Metab Dispos 1995;23:
1325–1334.
Chernushevich IV, Loboda AV, Thomson BA. An introduction to quadrupole-time-of-
flight mass spectrometry. J Mass Spectrom 2001;36:849–865.
Chovan LE, Black-Schaefer C, Dandliker PJ, Lau YY. Automatic mass spectrometry
method development for drug discovery: application in metabolic stability assays.
Rapid Commun Mass Spectrom 2004;18:3105–3112.
Chowdhury SK, Blumenkrantz N, Zhong R, Kulmatycki K, Wirth M, McNamara P,
Gopaul VS, Alton KB, Patrick JE. Detection and characterization of polar
metabolites by LC-MS: proper selection of LC column and use of stable isotope-
labeled drug to study metabolism of ribavirin in rats. In: Chowdhury S K, editor.
Identification and Quantification of Drugs, Metabolites and Metabolizing Enzymes
by LC-MS. Oxford: Elsevier; 2005. p 277–293.
Clarke NJ, Rindgen D, Korfmacher WA, Cox KA, Systematic LC/MS metabolite
identification in drug discovery. Anal Chem 2001;73:430A–439A.
Cody RB, Laramee JA, Durst HD. Versatile new ion source for the analysis of
materials in open air under ambient Conditions. Anal Chem 2005;77:2297–2302.
Cooks RG, Ouyang Z, Takats Z, Wiseman JM. Detection technologies. Ambient mass
spectrometry. Science 2006;311:1566–1570.
Corcoran O, Nicholson JK, Lenz EM, Abou-Shakra F, Castro-Perez J, Sage AB,
Wilson ID. Directly coupled liquid chromatography with inductively coupled
plasma mass spectrometry and orthogonal acceleration time-of-flight mass spectro-
metry for the identification of drug metabolites in urine: application to diclofenac
using chlorine and sulfur detection. Rapid Commun Mass Spectrom 2000;14:
2377–2384.
Cox KA. Special requirements for metabolite characterization. In: Korfmacher WA,
editor. Using Mass Spectrometry for Drug Metabolism Studies. CRC Press; Boca
Raton: 2005. p 229–252.
Dalvie DK, O’Donnell JP. Characterization of polar urinary metabolites by ionspray
tandem mass spectrometry following dansylation. Rapid Commun Mass Spectrom
1998;12:419–422.
Dams R, Huestis MA, Lambert WE, Murphy CM. Matrix effect in bio-analysis of
illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and
biofluid. J Am Soc Mass Spectrom 2003;14:1290–1294.
Davis-Bruno KL, Atrakchi A. A regulatory perspective on issues and approaches in
characterizing human metabolites. Chem Res Toxicol 2006;19:1561–1563.
Day SH, Mao A, White R, Schulz-Utermoehl T, Miller R, Beconi MG. A semi-
automated method for measuring the potential for protein covalent binding in drug
discovery. J Pharmacol Toxicol Methods 2005;52:278–285.
deHoffmann E. Tandem mass spectrometry: a primer. J Mass Spectrom 1996;31:129–
215.
Dear GJ, Plumb RS, Sweatman BC, Ayrton J, Lindon JC, Nicholson JK, Ismail IM.
Mass directed peak selection, an efficient method of drug metabolite identification
using directly coupled liquid chromatography-mass spectrometry-nuclear magnetic
resonance spectroscopy. J Chromatogr B 2000;748:281–293.
360 APPLICATION OF LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY